|The Medical Device Excise Tax: Frequently-Suspended Tax May Take Effect on January 1, 2020||December 11, 2019||Thomas Barker, Nicola Lemay, Haider David Andazola, Alyssa Pratt||Healthcare Alert|
|Massachusetts Department of Public Health’s Health Advisory on Grocery Stores and Pharmacies||March 27, 2020||Tad Heuer, Rachel Hutchinson, Jeremy W. Meisinger||Healthcare Alert|
|What Clinical Diagnostic Laboratories and Manufacturers Need to Know about the CARES Act||March 31, 2020||Brian P. Carey, Erik L. Schulwolf||Healthcare Alert|
|What Biopharmaceutical and Medical Device Manufacturers Need to Know About the CARES Act||April 1, 2020||Paul T. Kim, Areta Kupchyk, Haider David Andazola||Healthcare Alert|
|What Healthcare Providers Need to Know About the CARES Act||April 1, 2020||Thomas Barker, Ross Margulies||Healthcare Alert|
|New Federal COVID-19 Appropriations for Healthcare Providers: The Paycheck Protection Program and Health Care Enhancement Act||April 24, 2020||Thomas Barker, Brian P. Carey, Ross Margulies||Healthcare Alert|
|Public Health and Social Services Emergency Fund||May 14, 2020||Kristyn Bunce DeFilipp, Caroline Donovan, Michael Licker, Ross Margulies||Healthcare Alert|
|Massachusetts Board of Registration in Medicine Updated COVID-19 Related Orders on Licensure of Out-of-State Physicians and Telemedicine||July 6, 2020||Colin J. Zick||Healthcare Alert|
|FDA Releases Long-Awaited Draft Guidances on Biosimilar Product Development||February 9, 2012||Paul T. Kim, Barbara A. Fiacco, Donald R. Ware||Government Strategies Alert|
|FDA's Draft Guidance on Scientific Considerations in Demonstrating Biosimilarity||February 10, 2012||Paul T. Kim, Barbara A. Fiacco, Donald R. Ware||Government Strategies Alert|
Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK," you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you.
If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Foley Hoag.